e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Comorbidities in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
P. D. T. Muller, J. A. Neder, C. A. D. A. Viegas (Campo Grande, São Paulo, Brasília, Brazil)
Source:
Annual Congress 2008 - Comorbidities in COPD
Session:
Comorbidities in COPD
Session type:
E-Communication Session
Number:
4499
Disease area:
Airway diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. D. T. Muller, J. A. Neder, C. A. D. A. Viegas (Campo Grande, São Paulo, Brasília, Brazil). Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?. Eur Respir J 2008; 32: Suppl. 52, 4499
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Prevalence and characteristics of patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD): “overlap syndrome (OS)”
Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea
Year: 2020
Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome)
Source: Sleep and Breathing Conference 2021
Year: 2021
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
Chronic respiratory failure in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Bronchial inflammation in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 466s
Year: 2003
The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
CPAP therapy in idiopathic pulmonary fibrosis (IPF) patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010
High flow-nasal cannula oxygen treatment in patients with concomitant severe chronic obstructive pulmonary diseases and mild-moderate sleep apnea (overlap syndrome).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Smoking (active and former) among factors influencing severity of both pathologies in a population with obstructive sleep apnea (OSA) and chronic obstructive bronhopneumopathy (COPD)
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010
Analysis of pulmonary function and obstructive sleep apnea in patients with COPD, asthma and idiopathic pulmonary fibrosis.
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020
Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA).
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017
Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002
What causes morning tiredness in COPD patients?
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept